Treatment Resistance in Stem Cells and Breast Cancer

被引:69
作者
Dave, Bhuvanesh [1 ]
Chang, Jenny [1 ]
机构
[1] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA
关键词
Cancer stem cells; Breast; Therapy; Resistance; Clinical trials;
D O I
10.1007/s10911-009-9117-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer stem cells are resistant to current chemotherapy and radiation regimens available for breast cancer, making it imperative to study the mechanisms of resistance and development of therapeutic strategies that targets the tumor initiating cell population. One of the difficulties in identifying new drug targets has been that our current high throughput drug screens look for tumor shrinkage and do not incorporate the impact of compounds on the cancer stem cell population. In this review we discuss the literature on treatment resistance in breast cancer and the design of new clinical trials for test compounds which will allow us to determine both the reduction in tumor size and decrease in cancer stem cell population. In order to detect the effect of target compounds on cancer stem cells in a clinical setting, we will need to do multiple assays which include high throughput flow sorting analysis to determine the total number of CD44(+)/CD24(-/low)/Lin(-) and ALDH1 positive cells, as well as in-vitro mammosphere formation assay which is a functional assay dependent on the self renewal and anchorage independent growth properties of these cells.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 12 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]   Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases [J].
Brekelmans, C. T. M. ;
Tilanus-Linthorst, M. M. A. ;
Seynaeve, C. ;
Van der Ouweland, A. ;
Menke-Pluymers, M. B. E. ;
Bartels, C. C. M. ;
Kriege, M. ;
van Geel, A. N. ;
Burger, C. W. ;
Eggermont, A. M. M. ;
Meijers-Heijboer, H. ;
Klijn, J. G. M. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (05) :867-876
[3]   Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients [J].
Chang, JC ;
Wooten, EC ;
Tsimelzon, A ;
Hilsenbeck, SG ;
Gutierrez, MC ;
Tham, YL ;
Kalidas, M ;
Elledge, R ;
Mohsin, S ;
Osborne, CK ;
Chamness, GC ;
Allred, DC ;
Lewis, MT ;
Wong, H ;
O'Connell, P .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) :1169-1177
[4]   ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome [J].
Ginestier, Christophe ;
Hur, Min Hee ;
Charafe-Jauffret, Emmanuelle ;
Monville, Florence ;
Dutcher, Julie ;
Brown, Marty ;
Jacquemier, Jocelyne ;
Viens, Patrice ;
Kleer, Celina G. ;
Liu, Suling ;
Schott, Anne ;
Hayes, Dan ;
Birnbaum, Daniel ;
Wicha, Max S. ;
Dontu, Gabriela .
CELL STEM CELL, 2007, 1 (05) :555-567
[5]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[6]   The CD44+/CD24- phenotype is enriched in basal-like breast tumors [J].
Honeth, Gabriella ;
Bendahl, Par-Ola ;
Ringner, Markus ;
Saal, Lao H. ;
Gruvberger-Saal, Sofia K. ;
Lovgren, Kristina ;
Grabau, Dorthe ;
Ferno, Marten ;
Borg, Ake ;
Hegardt, Cecilia .
BREAST CANCER RESEARCH, 2008, 10 (03)
[7]  
Krop I.E., 2006, J Clin Oncol Meeting Abstr, V24, P10574, DOI DOI 10.1200/JCO.2006.24.18_SUPPL.1057424
[8]   Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy [J].
Li, Xiaoxian ;
Lewis, Michael T. ;
Huang, Jian ;
Gutierrez, Carolina ;
Osborne, C. Kent ;
Wu, Meng-Fen ;
Hilsenbeck, Susan G. ;
Pavlick, Anne ;
Zhang, Xiaomei ;
Chamness, Gary C. ;
Wong, Helen ;
Rosen, Jeffrey ;
Chang, Jenny C. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09) :672-679
[9]  
LORUSSO PM, 2008, J CLIN ONCOL S 0520, V26
[10]   CLONAL EVOLUTION OF TUMOR-CELL POPULATIONS [J].
NOWELL, PC .
SCIENCE, 1976, 194 (4260) :23-28